Shop
Cellestra-Mitozz
Quantity
What is Mitozz?
Mitozz is a next-generation nutraceutical powered by 98% pure (-)-epicatechin — a potent flavonoid derived from cacao and select botanicals. Supported by over 15 years of university-led research, Mitozz is engineered to re-energize your cellular mitochondria, the body's core energy producers.
Science-backed Formula:
Decades of research and over 200 clinical studies validate its effect on energy, metabolism, and long-term well-being.
Cellular Health Focus:
Designed to restore mitochondrial function, reduce oxidative stress, and promote youthful resilience from within.
Why Choose Mitozz?
Clinically Proven:
Unlike generic supplements, Mitozz is clinically shown to support key health markers including stamina, muscle recovery, metabolic balance, and healthy aging.
Deeper Impact:
Delivers support at the cellular level, improving your body's core energy system for sustained vitality.
Targeted Benefits:
From fatigue reduction and muscle repair to cardiovascular and metabolic health — Mitozz elevates your life performance.
Who Is Mitozz For?
- Adults over 35 who seek stronger energy and healthy aging.
- Those feeling occasional tiredness, decreased stamina, or struggling with recovery.
- Individuals committed to boosting cardiovascular and metabolic health, and active living.
- Athletes, high performers, or anyone not satisfied with ordinary wellness solutions.
Key Benefits
Enhances Cellular Energy
Fuels your mitochondria for consistent stamina throughout the day.
Reduces Oxidative Stress
Minimizes inflammation, helping cells recover and rejuvenate faster.
Supports Muscle Recovery
Accelerates repair after physical activity or strain.
Optimizes Metabolic Health
Encourages balanced metabolism for better overall vitality.
Promotes Healthy Aging
Sustains cellular health for resilience and longevity.
Exclusive Offer
Advanced cellular supplement at special introductory prices in India.
No compromise
Authentic formula, delivered direct from global research labs to Indian households.
